Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| BNP Paribas | 3.78% | $11.46M | €88.95B | 39.93% | 77 Outperform | |
| ORANGE SA | 3.75% | $11.38M | €37.37B | 47.51% | 65 Neutral | |
| AstraZeneca | 3.64% | $11.05M | $286.45B | 38.98% | 79 Outperform | |
| NN Group N.V. | 3.47% | $10.54M | €16.56B | 57.86% | 68 Neutral | |
| E.ON SE | 3.24% | $9.82M | €41.77B | 42.42% | 61 Neutral | |
| Roche Holding AG | 3.21% | $9.74M | CHF263.28B | 47.53% | 73 Outperform | |
| Mitsubishi UFJ Financial Group | 3.10% | $9.42M | ¥27.74T | 40.43% | 76 Outperform | |
| ING GROEP | 2.94% | $8.93M | €70.27B | 61.12% | 61 Neutral | |
| TotalEnergies SE | 2.93% | $8.89M | €119.96B | 2.56% | 78 Outperform | |
| Iberdrola | 2.75% | $8.35M | €120.76B | 39.79% | 67 Neutral |